1. Committee of Pharmacopoeia of China . Pharmacopoeia of People’s Republic of China 2015 edition. The Medicine Science and Technology of China Press; 2015.
Google Scholar2. Hosseinzadeh, H, Nassiri-Asl, M. Pharmacological effects of Glycyrrhiza spp. and its bioactive constituents: update and review. Phytother Res. 2015;29(12):1868–1886.
Google Scholar | Crossref | Medline3. Ming Yang, YJ, Li-Ping, Y. A systematic summary of natural compounds in radix Glycyrrhizae. Tradit Med Res. 2018;3(2):82–94.
Google Scholar4. COVID-19 Treatment Guidelines Panel . Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. N.I.o. Health, Editor. 2020, National Institutes of Health.
Google Scholar5. Ali, I, Alharbi, OML. COVID-19: disease, management, treatment, and social impact. Sci Total Environ. 2020;728:138861.
Google Scholar | Crossref | Medline6. Ang, L, Lee, HW, Choi, JY, Zhang, J, Soo Lee, M. Herbal medicine and pattern identification for treating COVID-19: a rapid review of guidelines. Integr Med Res. 2020;9(2):100407.
Google Scholar | Crossref | Medline7. National Health Commission & State Administration of Traditional Chinese Medicine . Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia. N.H.C.o.t.P.s.R.o. China, Editor. 2020, National Health Commission of the People’s Republic of China; 32.
Google Scholar8. Luo, H, Tang, QL, Shang, YX, et al. Can Chinese medicine be used for prevention of corona virus disease 2019 (COVID-19)? A review of historical classics, research evidence and current prevention programs. Chin J Integr Med. 2020;26(4):243–250.
Google Scholar | Crossref | Medline9. Ren, JL, Zhang, AH, Wang, XJ. Traditional Chinese medicine for COVID-19 treatment. Pharmacol Res. 2020;155:104743–104743.
Google Scholar | Crossref | Medline10. Wang, Z, Chen, X, Lu, Y, Chen, F, Zhang, W. Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. Biosci Trends. 2020;14(1):64–68.
Google Scholar | Crossref | Medline11. Zhou, Y, Fu, B, Zheng, X. Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients. Natl Sci Rev. 2020;7(6):998–1002.
Google Scholar | Crossref12. Wen, J, Wang, R, Liu, H. Potential therapeutic effect of Qingwen baidu decoction against corona virus disease 2019: a mini review. Chin Med. 2020;15(1):48.
Google Scholar | Crossref | Medline13. Ren, X, Shao, XX, Li, XX. Identifying potential treatments of COVID-19 from Traditional Chinese Medicine (TCM) by using a data-driven approach. J Ethnopharmacol. 2020;258:112932.
Google Scholar | Crossref | Medline14. Conway, J. Dollar Sales of the Leading Licorice Brands in the U.S. 2019. Accessed March 17, 2021. https://www.statista.com/statistics/190418/top-licorice-candy-brands-in-the-united-states/
Google Scholar15. Zheng, Y . A Healthy Way of Nursing. 2019. Accessed March 17, 2021. https://www.chinadaily.com.cn/a/201908/12/WS5d50a0b6a310cf3e35565167.html
Google Scholar16. Huang, YF, Bai, C, He, F, Xie, Y, Zhou, H. Review on the potential action mechanisms of Chinese medicines in treating Coronavirus Disease 2019 (COVID-19). Pharmacol Res. 2020;158:104939.
Google Scholar | Crossref | Medline17. Zhang, DH, Wu, KL, Zhang, X, Deng, SQ, Peng, B. In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. J Integr Med. 2020;18(2):152–158.
Google Scholar | Crossref | Medline18. Khan, SA, Zia, K, Ashraf, S, Uddin, R, Ul-Haq, Z. Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach. J Biomol Struct Dyn. 2020:1–10.
Google Scholar19. Chenghao, Y, Gao, M, Lin, W, Yu, K, Li, P, Chen, G. Theoretical study of the anti-NCP molecular mechanism of Traditional Chinese Medicine Lianhua-Qingwen Formula (LQF). ChemRxiv Preprint. 2020.
Google Scholar20. Yang L, YT, Miao, J, et al. Network pharmacology studies on the effect of Chai-Ling decoction in coronavirus disease 2019. Tradit Med Res. 2020;5(3):145–159.
Google Scholar21. Zhong, LLD, Lam, WC, Yang, W, et al. Potential targets for treatment of coronavirus disease 2019 (COVID-19): a review of Qing-Fei-Pai-Du-Tang and its major herbs. Am J Chin Med. 2020;48(5):1051–1071.
Google Scholar | Crossref | Medline22. Cinatl, J, Morgenstern, B, Bauer, G, Chandra, P, Rabenau, H, Doerr, HW. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet. 2003;361(9374):2045–2046.
Google Scholar | Crossref | Medline23. Wu, CY, Jan, JT, Ma, SH, et al. Small molecules targeting severe acute respiratory syndrome human coronavirus. Proc Natl Acad Sci U S A. 2004;101(27):10012–10017.
Google Scholar | Crossref | Medline24. Hoever, G, Baltina, L, Michaelis, M, et al. Antiviral activity of glycyrrhizic acid derivatives against SARS−Coronavirus. J Med Chem. 2005;48(4):1256–1259.
Google Scholar | Crossref | Medline25. Chen, F, Chan, KH, Jiang, Y, et al. In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds. J Clin Virol. 2004;31(1):69–75.
Google Scholar | Crossref | Medline26. Yang, R, Liu, H, Bai, C, et al. Chemical composition and pharmacological mechanism of Qingfei Paidu decoction and ma Xing Shi Gan decoction against coronavirus disease 2019 (COVID-19): in silico and experimental study. Pharmacol Res. 2020;157:104820.
Google Scholar | Crossref | Medline27. Yue, GG, Chan, BC, Kwok, HF, et al. Screening for anti-inflammatory and bronchorelaxant activities of 12 commonly used Chinese herbal medicines. Phytother Res. 2012;26(6):915–925.
Google Scholar | Crossref | Medline28. Yang, EJ, Song, IS, Song, KS. Ethanol extract of Glycyrrhizae Radix modulates the responses of antigen-specific splenocytes in experimental autoimmune encephalomyelitis. Phytomedicine. 2019;54:56–65.
Google Scholar | Crossref | Medline29. Ma, C, Ma, Z, Liao, XL, Liu, J, Fu, Q, Ma, S. Immunoregulatory effects of glycyrrhizic acid exerts anti-asthmatic effects via modulation of Th1/Th2 cytokines and enhancement of CD4(+)CD25(+)Foxp3+ regulatory T cells in ovalbumin-sensitized mice. J Ethnopharmacol. 2013;148(3):755–762.
Google Scholar | Crossref | Medline30. Guo, A, He, D, Xu, HB, Geng, CA, Zhao, J. Promotion of regulatory T cell induction by immunomodulatory herbal medicine licorice and its two constituents. Sci Rep. 2015;5(1):14046.
Google Scholar | Crossref | Medline31. Hong, YK, Wu, HT, Ma, T, Liu, WJ, He, XJ. Effects of Glycyrrhiza glabra polysaccharides on immune and antioxidant activities in high-fat mice. Int J Biol Macromol. 2009;45(1):61–64.
Google Scholar | Crossref | Medline | ISI32. Harish, R, Chauhan, JB. Antioxidant, antimicrobial and cytoprotective action of ethanolic extract of Glycyrrhiza glabra root against ccl4 induced damage on Saccharomyces cerevisiae. J Pharmacogn Phytochem. 2019;8(3):247–253.
Google Scholar33. Zhang, CH, Yu, Y, Liang, YZ, Chen, XQ. Purification, partial characterization and antioxidant activity of polysaccharides from Glycyrrhiza uralensis. Int J Biol Macromol. 2015;79:681–686.
Google Scholar | Crossref | Medline34. Kuang, Y, Li, B, Fan, J, Qiao, X, Ye, M. Antitussive and expectorant activities of licorice and its major compounds. Bioorg Med Chem. 2018;26(1):278–284.
Google Scholar | Crossref | Medline35. Nazari, S, Rameshrad, M, Hosseinzadeh, H. Toxicological effects of Glycyrrhiza glabra (Licorice): a review. Phytother Res. 2017;31(11):1635–1650.
Google Scholar | Crossref | Medline36. Lu, L, Li, F, Wen, H, et al. An evidence mapping and analysis of registered COVID-19 clinical trials in China. BMC Med. 2020;18(1):167.
Google Scholar | Crossref | Medline37. Luo, E, Zhang, D, Luo, H, et al. Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): an empirical study from Wuhan, Hubei Province, China. Chin Med. 2020;15(1):34.
Google Scholar | Crossref | Medline